Tushar Pandey: From ITP to TTP in Clinical Practice
Tushar Pandey, Director and Head of Raghav Institute of Hematology, Hemato-Oncology and BMT at Raghav Healthcare, Editorial Board Member at Journal of Cancer Chemotherapy, Program Director of Hemato – Oncology at International Association For Integrated Oncology, shared a post on LinkedIn:
“Always a pleasure to speak about thrombocytopenia, especially ITP and TTP.
These conditions are commonly seen but still challenge clinicians due to their changing presentations, evolving evidence, and the need for timely and accurate decision-making.
From immune thrombocytopenia (ITP), where individualized treatment and long-term disease control are essential, to thrombotic thrombocytopenic purpura (TTP), a true hematologic emergency requiring rapid recognition and intervention, they reflect the complexity of real – world hematology practice.
Each opportunity like this helps bridge guidelines with real – life practice, ensuring patients receive evidence – based, practical, and life – saving care.
Grateful to contribute to the advancement of hematology, hemato-oncology, and BMT through knowledge sharing and clinical excellence.”
Stay updated with Hemostasis Today.
-
Sep 13, 2026, 05:36Speaking Up When Women’s Health Concerns Are Dismissed – Haemophilia Foundation Australia
-
Sep 13, 2026, 05:16W. Alberto Sifuentes Giraldo: Dual Targeted Therapy Shows Promise in Refractory Systemic Autoinflammatory Diseases
-
Sep 13, 2026, 04:42Christopher Robinson: Early Pregnancy Oxylipins May Signal Risk of Fetal Growth Restriction
-
Sep 13, 2026, 04:22Gabriela Hobbs: 2026 Society of Hematologic Oncology Meeting
-
Sep 13, 2026, 03:40Mizinga Moonze: When Blood Speaks – The Missing Link in Healthcare Sustainability
-
Sep 12, 2026, 17:55Dries De Wolf: Honored to Have Wolfgang Miesbach Comment on Our Latest Research
-
Sep 12, 2026, 17:53Usman Waheed: Introducing the Discovery of the 49th ISBT Blood Group System
-
Sep 12, 2026, 17:51Maria Sabater Lleal: Happy to Share Our Latest Work Exploring the Genetic Determinants of PE in VTE
-
Sep 12, 2026, 17:51Jeff Sternlicht: Why LDL-C and ApoB Remain King of the Hill?